News
C3.ai's announcement of a new CEO, coupled with a solid plan to regain growth could lift the sentiment. Click here to read an ...
1d
TipRanks on MSNSOUN or C3.ai: Which AI Stock Is the Smarter Buy for 2025?
As investors plan for 2025, AI stocks are getting a lot of attention. Companies like SoundHound AI ($SOUN) and C3.ai ($AI) ...
OpenAI CEO Sam Altman has given renewed voice to concerns about an AI bubble. Altman recently told reporters that investors ...
3d
Zacks Investment Research on MSNC3.ai, Inc. (AI) Is a Trending Stock: Facts to Know Before Betting on It
C3.ai, Inc. (AI) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider ...
With bad news continuing to pile onto the stock, C3.ai stock has not only plunged to a new 52-week low, it has hit levels it ...
PATH powers growth with its AI-driven automation platform, posting rising revenues, strong adoption and a major buyback plan.
The law firm of Kessler Topaz Meltzer & Check, LLP ( is currently investigating potential violations of the federal securities laws on behalf of investors of C3.ai, Inc. (NYSE: AI) (“C3”). On August 8 ...
C3.ai, Inc. AI recently announced a partnership with Eletrobras — Latin America’s largest power utility — to scale its Grid ...
Investing.com -- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) stock surged 23% after the FDA lifted a clinical hold on the company’s pivotal Phase 2 trial of RP-A501 for the treatment of Danon disease.
C3.ai, Inc. (NYSE:AI) is one of the AI Stocks In The Spotlight For Investors. On August 18, C3 AI and Brazilian power company ...
C3.ai Inc. closed 61.45% below its 52-week high of $45.08, which the company reached on December 10th.
A number of stocks fell in the afternoon session after investors took some profits off the table as markets awaited signals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results